Evidence map›Paper›PMID 31781300›Full record

ArticleDisease markers2019

Determination of

Virgilijus Uloza, Toma Tamauskaite, Alvita Vilkeviciute, Agne Pasvenskaite, Vykintas Liutkevicius, Rasa Liutkeviciene

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Exploring the Role ofJournal of clinical medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.International journal of clinical and experimental pathology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Virgilijus UlozaDepartment of Otolaryngology, Academy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Toma TamauskaiteAcademy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Alvita VilkeviciuteNeuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-0427-5568
Agne PasvenskaiteDepartment of Otolaryngology, Academy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Vykintas LiutkeviciusDepartment of Otolaryngology, Academy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-7349-4844
Rasa LiutkevicieneNeuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.ORCID https://orcid.org/0000-0001-5395-923X
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine the frequency of the genotype of signal transducer and activator of transcription protein 3 (STAT3) rs744166, sirtuin (SIRT1) rs12778366, fibroblast growth factor (FGFR2) rs2981582, and advanced glycosylation end product-specific receptor (RAGE) rs1800625 gene polymorphisms in patients with laryngeal squamous cell carcinoma (LSCC).

methodsA total of 944 subjects were evaluated, which includes 144 patients with LSCC and 800 healthy controls. The genotyping of

resultsThe analysis of

conclusion

Indexed as

Polymorphism, Single NucleotideAdultAgedAged, 80 and overAntigens, NeoplasmBiomarkers, TumorCarcinoma, Squamous CellCase-Control StudiesFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenotypeHumansLaryngeal NeoplasmsMaleMiddle AgedAntigens, NeoplasmBiomarkers, TumorFGFR2 protein, humanMitogen-Activated Protein KinasesMOK protein, humanReceptor, Fibroblast Growth Factor, Type 2SIRT1 protein, humanSirtuin 1STAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID31781300
PMCPMC6875326
OpenAlexW2987609871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.